IDEXX LABORATORIES INC /DE — Director's Dealing 2020

Dec 11, 2020

SEC Form 4/A — Form 4/A

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2020-11-02

Reporting Person: AYERS JONATHAN W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-11-02	Common Stock	F	26120	$424.82	Disposed	737347	Direct
2020-11-02	Common Stock	S	2725	$429.9346	Disposed	734622	Direct
2020-11-02	Common Stock	S	2102	$430.7172	Disposed	732520	Direct
2020-11-02	Common Stock	S	500	$432.2790	Disposed	732020	Direct
2020-11-02	Common Stock	S	1015	$433.4204	Disposed	731005	Direct
2020-11-02	Common Stock	S	1285	$434.4719	Disposed	729720	Direct
2020-11-02	Common Stock	S	773	$435.5271	Disposed	728947	Direct
2020-11-02	Common Stock	S	300	$436.7016	Disposed	728647	Direct
2020-11-02	Common Stock	S	400	$438.5425	Disposed	728247	Direct
2020-11-02	Common Stock	S	800	$439.5943	Disposed	727447	Direct
2020-11-02	Common Stock	S	100	$440.23	Disposed	727347	Direct
2020-11-03	Common Stock	S	134	$437.32	Disposed	727213	Direct
2020-11-03	Common Stock	S	700	$439.5582	Disposed	726513	Direct
2020-11-03	Common Stock	S	400	$440.09	Disposed	726113	Direct
2020-11-03	Common Stock	S	1357	$442.1377	Disposed	724756	Direct
2020-11-03	Common Stock	S	3622	$443.8421	Disposed	721134	Direct
2020-11-03	Common Stock	S	3011	$444.6942	Disposed	718123	Direct
2020-11-03	Common Stock	S	908	$446.0159	Disposed	717215	Direct
2020-11-03	Common Stock	S	300	$446.98	Disposed	716915	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	10000	Indirect

Footnotes

F1: Shares withheld for the payment of taxes on the conversion of 14,791 deferred stock units ('DSUs') acquired pursuant to the IDEXX Laboratories, Inc. Executive Deferred Compensation Plan and which were reported previously on Table I and represented a right to receive one share of Issuer common stock without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on November 7, 2007 and on June 15, 2015 (the "Stock Splits"). The total number of securities previously reported as beneficially owned, as adjusted to reflect the Stock Splits, is 59,164 DSUs, which were converted to an equal number of shares of Issuer common stock one year following the reporting person's resignation as an executive from IDEXX Laboratories, Inc.

F2: Represents the weighted average price of the shares sold ranging from a low of $429.39 to a high of $430.375 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F3: Represents the weighted average price of the shares sold ranging from a low of $430.42 to a high of $431.28 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F4: Represents the weighted average price of the shares sold ranging from a low of $431.815 to a high of $432.72 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F5: Represents the weighted average price of the shares sold ranging from a low of $432.96 to a high of $433.96 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F6: Represents the weighted average price of the shares sold ranging from a low of $433.99 to a high of $434.88 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F7: Represents the weighted average price of the shares sold ranging from a low of $435.17 to a high of $436.10 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F8: Represents the weighted average price of the shares sold ranging from a low of $436.18 to a high of $437.04 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F9: Represents the weighted average price of the shares sold ranging from a low of $438.01 to a high of $439.00 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F10: Represents the weighted average price of the shares sold ranging from a low of $439.045 to a high of $439.83 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F11: Represents the weighted average price of the shares sold ranging from a low of $439.029 to a high of $439.77 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F12: Represents the weighted average price of the shares sold ranging from a low of $441.89 to a high of $442.77 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F13: Represents the weighted average price of the shares sold ranging from a low of $443.17 to a high of $444.10 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F14: Represents the weighted average price of the shares sold ranging from a low of $444.35 to a high of $445.27 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F15: Represents the weighted average price of the shares sold ranging from a low of $445.46 to a high of $446.31 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F16: Represents the weighted average price of the shares sold ranging from a low of $446.74 to a high of $447.10 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.